Heron Therapeutics Inc HRTX:NASDAQ

Last Price$17.94Cboe Real-Time Last Sale as of 10:14AM ET 5/29/20
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change-0.48(2.61%)
Bid (Size)$17.91 (300)
Ask (Size)$17.97 (200)
Day Low / High$18.02 - 18.42
Volume34.7 K
 

View Biotechnology IndustryPeer Comparison as of 05/29/2020

 

Heron Therapeutics Inc ( NASDAQ )

Price: $17.94
Change: -0.48 (2.61%)
Volume: 34.7 K
10:14AM ET 5/29/2020
 
 

Akebia Therapeutics Inc ( NASDAQ )

Price: $11.15
Change: -0.36 (3.13%)
Volume: 153.4 K
10:14AM ET 5/29/2020
 
 

Adverum Biotechnologies Inc ( NASDAQ )

Price: $18.81
Change: -1.51 (7.43%)
Volume: 270.7 K
10:14AM ET 5/29/2020
 
 

Ligand Pharmaceuticals Inc ( NASDAQ )

Price: $99.85
Change: -0.94 (0.93%)
Volume: 15.1 K
10:12AM ET 5/29/2020
 
 

Sangamo Therapeutics Inc ( NASDAQ )

Price: $11.23
Change: -0.21 (1.84%)
Volume: 169.8 K
10:14AM ET 5/29/2020
 

Read more news Recent News

Analyst Actions: Guggenheim Starts Heron Therapeutics at Buy With $24 Price Target
9:28AM ET 5/27/2020 MT Newswires

Heron Therapeutics (HRTX) has an average analyst rating of buy, with an average price target of $42. Price: 19.05, Change: +0.61, Percent Change: +3.31 ...

Heron Therapeutics Commences Clinical Trial of Post-Operative Pain Medication
9:32AM ET 5/18/2020 MT Newswires

Heron Therapeutics (HRTX) said Monday that it has begun a phase 1b/2 clinical trial of HTX-034, the company's next-generation product for the treatment of...

Heron Therapeutics Q1 Loss Narrows, Revenue Declines
12:18PM ET 5/06/2020 MT Newswires

Heron Therapeutics (HRTX) on Wednesday posted a Q1 loss of $0.57, narrowing from $0.80 loss a year ago. Analysts polled by Capital IQ had expected a loss...

Heron Therapeutics Slips After Posting Worse-Than-Expected Q4 Loss Per Share; Revenue Tops Consensus
2:28PM ET 3/02/2020 MT Newswires

Heron Therapeutics (HRTX) on Monday posted a Q4 net loss of $0.65 per share, compared with a net loss of $0.63 per share a year earlier and wider than the...

Company Profile

Business DescriptionHeron Therapeutics, Inc. is a biotechnology company, which engages in the development of pharmaceutical products for patients suffering from cancer. Its products portfolio include SUSTOL, Cinvanti, HTX-011, and HTX-034. The company was founded in February 1983 and is headquartered in Redwood City, CA. View company web site for more details
Address4242 Campus Point Court
San Diego, California 92121
Phone+1.858.251.4400
Number of Employees198
Recent SEC Filing05/18/20208-K
President, Chief Executive Officer & DirectorBarry D. Quart
Chief Financial Officer & Senior VP-FinanceRobert E. Hoffman
Chief Scientific Officer & SVP-PharmaceuticalThomas B. Ottoboni
Chief Medical OfficerChris M. Storgard

Company Highlights

Price Open$18.26
Previous Close$18.42
52 Week Range$9.60 - 26.81
Market Capitalization$1.6 B
Shares Outstanding90.6 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement08/03/2020

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$2.27
Beta vs. S&P 500N/A
Revenue$77.5 M
Net Profit Margin-138.31%
Return on Equity-56.85%

Analyst Ratings as of 05/22/2020

Buy
10
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset